DOI: 10.36871 / EK.UP.PR2020.04.01.018
UDC 338.012

Authors

A. R. SKRIPNIK
FINANCIAL UNIVERSITY UNDER THE GOVERNMENT OF THE RUSSIAN FEDERATION, MOSCOW, RUSSIA

Abstract

The article determines the relevance of conducting clinical and economic research in assessing healthcare technologies in Russia. Analyzed publications on the results of clinical and economic research. The main methods used in the analysis of the feasibility of introducing technology into the healthcare system are identified. Deficiencies of current research, their methodological quality and current regulatory legal acts are revealed.

Keywords

clinical and economic analysis, pharmacoeconomics, technology, healthcare, analysis, impact, budget, costs, efficiency.